CSF1R inhibitors mitigate CDK4/6 inhibitor-induced immunosuppression to increase antitumor immunity in HR+/HER2- breast cancer.
Saved in:
| Title: | CSF1R inhibitors mitigate CDK4/6 inhibitor-induced immunosuppression to increase antitumor immunity in HR+/HER2- breast cancer. |
|---|---|
| Authors: | Li S; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Gong Y; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Li H; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Liu S; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Yin Y; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Yu Y; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Chu Y; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Hou J; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Liu J; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Zhang H; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Nanding A; Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, China., Yuan W; Institute of Cancer Prevention and Treatment, Harbin Medical University, Harbin, China.; Institute of Cancer Prevention and Treatment, Heilongjiang Academy of Medical Sciences, Harbin, China., Zhang Y; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Wang Q; Department of Scientific Research, Harbin Medical University Cancer Hospital, Harbin, China., Wu H; Sino-Russian Medical Research Center, Harbin Medical University Cancer Hospital, Harbin, China., Zhang X; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China. zhangxianyu@ems.hrbmu.edu.cn., Pang D; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China. pangda@ems.hrbmu.edu.cn. |
| Source: | Oncogene [Oncogene] 2026 Jun; Vol. 45 (21), pp. 1970-1987. Date of Electronic Publication: 2026 Apr 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
